Page last updated: 2024-09-05

dabigatran and Carcinogenesis

dabigatran has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, ET; Gilmour, SK; Minton, AR; Peters, MC; van Ryn, J	1

Other Studies

1 other study(ies) available for dabigatran and Carcinogenesis

Article	Year
Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment. Oncotarget, 2016, Dec-20, Volume: 7, Issue:51 Topics: Animals; Antithrombins; Blood Platelets; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cells, Cultured; Cisplatin; Cytokines; Cytotoxicity, Immunologic; Dabigatran; Dendritic Cells; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Ovarian Neoplasms; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays	2016

Article

Year

Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.

Oncotarget, 2016, Dec-20, Volume: 7, Issue:51

Topics: Animals; Antithrombins; Blood Platelets; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Growth Processes; Cells, Cultured; Cisplatin; Cytokines; Cytotoxicity, Immunologic; Dabigatran; Dendritic Cells; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Ovarian Neoplasms; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays

2016